Qiagen NV | QIA - Le Bénéfice D'Exploitation

Prix De L'Action
28.51
Variation Quotidienne
-0.62 -2.11%
Mensuellement
-17.46%
Annuel
-24.49%
Q2 Prévisions
31.88




Le Bénéfice D'Exploitation Changement Date
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
argenx SE USD 371.14M 21.17M 2025-12
Avita Medical AUD -10.41M 742K 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Ionis Pharmaceuticals USD -118M 97M 2026-03
IQVIA Holdings USD 2.68B 2.1B 2025-12
Moderna USD -857M 597M 2025-12
Organon & Co USD 388M 62M 2025-09
Qiagen NV USD 121.88M 15.41M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Tectonic Therapeutic USD -21.52M 374K 2025-12
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12